The BioInsights Podcast

BioInsights
  • 5.0 (4)
  • LIFE SCIENCES
The BioInsights Podcast

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

  1. MAR 27

    Enhancing mRNA results through strategic RNA design and quality control

    In the last few years, mRNA has moved to the fore in the vaccine and cell and gene therapy fields, and as a result, its successful production for these downstream applications has never been more crucial. In this podcast episode, Róisin McGuigan, Editor, Nucleic Acid Insights, speaks to Ryan Lahr, Senior R&D Scientist, CELLSCRIPT, about design, production, and quality control of synthesized mRNA for translation in cells.

    13 min

  2. MAR 13

    For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications

    Roisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Stanley Crooke, Chairman, Founder and CEO, n-Lorem, about his long career and pioneering role in the antisense oligonucleotide (ASO) space, how RNA-targeting therapies are set to enter the mainstream, and his latest focus: making personalized, free-for-life ASO therapies available to nano-rare patient populations.

    19 min

  3. FEB 19

    Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space

    Róisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Ketaki Deshmukh, Senior Scientist, Novo Nordisk, about advanced characterization tools for LNPs, challenges in extrahepatic delivery, scalability issues, and the potential impact of AI and machine learning (ML) on future LNP development.

    15 min

  4. JAN 27

    Driving innovation in cell and gene therapy: the role of AI and robotics

    Jokūbas Leikauskas, Editor, Cell & Gene Therapy Insights, speaks with OmniaBio Inc.’s Kenneth Harris, Chief Strategy Officer and Head of AI, Mitchel Sivilotti, President and CEO, and Anthony Rotunno, Senior Vice President and General Manager/Site Head, about the innovative advancements in cell and gene therapy, focusing on how AI, automation, and robotics are revolutionizing manufacturing processes by reducing costs, increasing production capacity, and ultimately, improving patient outcomes in the rapidly evolving cell and gene therapy field.

    16 min

  5. 12/06/2024

    Spatial mapping: shaping the future of I-O diagnostics and treatment

    Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with Banafshé Larijani, Director of the Centre for Therapeutic Innovation, University of Bath, about the development and application of a novel spatial mapping technology designed to improve cancer diagnostics and personalize treatment planning.

    39 min

  6. 12/05/2024

    Pioneering quality control in biomanufacturing of cell and gene therapies

    Lauren Coyle, Commissioning Editor, speaks with Dhruv Sareen, Executive Director at Cedars-Sinai Biomanufacturing Center, and Johnathan Rodriguez, Quality Control Manager at Cedars-Sinai Biomanufacturing Center, about the roles of in-process controls, method validation, risk management, and automation in biomanufacturing. They will highlight strategies to ensure product safety, consistency, and regulatory compliance for cell and gene therapy products.

    28 min

  7. 09/06/2024

    Preparing for tomorrow’s cell and gene therapies today: lessons from 30 years in the field

    For the first time in history, cell and gene therapy products are reaching the market in waves rather than in one’s and two’s, creating unprecedented challenges for pharma/biotech and healthcare sector stakeholders alike. David McCall, Senior Editor, BioInsights, speaks to Eric Faulkner, President and Chief Strategist, Passage Health Associates, about the chequered history of market access in the advanced therapies field, and what lessons can be taken forward to ensure a successful and sustainable commercial future for the sector.

    26 min

  8. 06/14/2024

    Insights into advanced therapies in the context of evolving funding and M&A environments

    David McCall, Senior Editor, BioInsights, spoke to Lee Brown, Healthcare Sector Global Team Leader, Third Bridge Group, on Tuesday, February 6, 2024 to gain his insights into the fast-moving market landscape of advanced therapies. The discussion outlines key recent news and strategic moves from prominent pharma and biotech companies in the field, as well as the prospects for specific technologies such as CRISPR-based genome editing and next-generation CAR-T therapies.

    23 min
See All (53)

Ratings & Reviews

5
out of 5
4 Ratings

About

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

Information

  • Creator
    BioInsights
  • Years Active
    2022 - 2025
  • Episodes
    53
  • Rating
    Clean
  • Copyright
    © 2025 The BioInsights Podcast
  • Show Website
    The BioInsights Podcast

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada